Treatment of chronic diseases such as cancer, hepatitis, COPD, cardiovascular diseases and other viral diseases such as HIV often require complex surgeries thus, involving suturing. These diseases are persistent and have long-lasting effects on a patient’s health. Therefore, the increasing prevalence of chronic diseases is also a key factor driving the surgical sutures market.

According to American Health Association, the total number of all U.S. registered hospitals were 5,564, number of rural community hospitals was 1,829, and the number of urban community hospitals was 3,033, in 2015. As per the data of the Government of India, the number of government hospitals was 35,416, in 2013. According to the report on Australia’s hospital (2014-15) by Australian Institute of Health and Welfare, in 2014, a total number of 1,322 hospitals were present in Australia.

Download Report Sample at:

Europe is the second largest market for surgical sutures, after North America. Germany has been the largest contributor to the European surgical sutures market, historically, followed by the U.K. and France. The European market is projected to grow on account of increasing aging population, rising prevalence of diabetes, and obesity in the region.

The surgical sutures market is expected to witness the fastest growth in Asia-Pacific during the forecast period. Increase in the aging population, increasing prevalence of diabetes, and surge in the number of burn cases in the region are some of the factors driving the Asia-Pacific market.

Some of the other key players operating in the surgical sutures industry include DemeTECH Corporation, Sutures India Pvt. Ltd., Zipline Medical, Inc., Peters Surgical, EndoEvolution, LLC, Johnson & Johnson, B. Braun Melsungen AG, Boston Scientific Corporation, and Smith & Nephew PLC.


Pas de commentaire à afficher.